The Role of Calcitonin for Fracture Pain

Brown JP Josse RG Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002; 167 (10 Suppl): S1–34

Silverman SL . Calcitonin. Endocrinol Metab Clin North Am 2003; 32 (1): 273–84

Miacalin NS (synthetic salmon calcitonin) product monograph. Novartis Pharmaceuticals Canada Inc., Dorval, QC. August 1, 2000

Blau LA Hoehns JD . Analgesic efficacy of calcitonin for vertebral fracture pain. Ann Pharmacother 2003; 37 (4): 564–70

Lyritis GP Paspati I Karachalios T . Pain relief from nasal salmon calcitonin in osteoporotic vertebral crush fractures. A double blind, placebo-controlled clinical study. Acta Orthop Scand Suppl 1997; 275:112–4

Lyritis GP Ioannidis GV Karachalios T . Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study. Clin J Pain 1999; 15 (4): 284–9

Levernieux J Julien D Caulin F . The effect of calcitonin on bone pain and acute resorption related to recent osteoporotic crush fractures: results of a double-blind and an open study. In: Cecchettin M Segre G , editors. Calciotropic hormones and calcium metabolism. Amsterdam: Elsevier; 1986: 171–8

Silverman SL Azria M . The analgesic role of calcitonin following osteoporotic fracture. Osteoporos Int 2002; 13 (11): 858–67

Azria M . Possible mechanisms of the analgesic action of calcitonin. Bone 2002; 30 (5 Suppl): 80S–83S

Lyritis GP Ioannidis GV Karachalios T . Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study. Clin J Pain 1999; 15 (4): 284–9

Silverman SL . Calcitonin. Rheum Dis Clin North Am 2001; 27 (1): 187–96

Huusko TM Karppi P Kautiainen H . Randomized, double-blind, clinically controlled trial of intranasal calcitonin treatment in patients with hip fracture. Calcif Tissue Int 2002; 71 (6): 478–84

Gennari C Agnusdei D Gonnelli S Maloli M . Bone pain in osteoporosis. In: Nordin BE , editor. Osteoporosis: contributions to modern management. Carnforth, England: Parthenon Publications; 1990: 57–64

Pun KK Chan LW . Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin Ther 1989; 11 (2): 205–9

Ljunghall S Gardsell P Johnell O . Synthetic human calcitonin in postmenopausal osteoporosis: a placebo-controlled, double-blind study. Calcif Tissue Int 1991; 49 (1): 17–9

Lyritis GP Tsakalakos N Magiasis B . Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: a double-blind placebo-controlled clinical study. Calcif Tissue Int 1991; 49 (6): 369–72

Attali G Levernieux J Caulin F . Recent crush fracture syndrome. Effect of salmon calcitonin: results of three double-blind studies and one open study. In: Christiansen C Johansen JS Riis BJ , eds. Osteoporosis. Copenhagen: Osteopress 1987:930–2

Combe B Cohen C Aubin F . Equivalence of nasal spray and subcutaneous formulations of salmon calcitonin. Calcif Tissue Int 1997; 61 (1): 10–5

Pontiroli AE Pajetta E Scaglia L . Analgesic effect of intranasal and intramuscular salmon calcitonin in postmenopausal osteoporosis: a double-blind, double-placebo study. Aging (Milano) 1994; 6 (6): 459–63

Gennari C Agnusdei D Gonnelli S . Confirmation of the analgesic efficacy of Miacalcic nasal in the treatment of postmenopausal osteoporosis. In: Peck WA , editor. Prevention of postmenopausal osteoporosis: dream or reality? Carnforth, England: Parthenon; 1990: 65–74

Anderson C . What's new in pain management? Home Healthc Nurse 2000; 18 (10): 648–58